Pharmaceutical company invests $80M to expand Dothan distribution center

Cencora, formerly known as AmeriSourceBergen, recently announced a new $1 billion investment plan which includes an expanded presence in the Wiregrass.

The global pharmaceutical solutions company will put $80 million toward expanding its distribution center in Dothan.

“Healthcare providers rely on us to provide efficient access to the medications their patients need, and we’re able to deliver on that promise because of the robust distribution infrastructure and operations we’ve built through decades of investment. This investment underscores our commitment to and role in building a resilient pharmaceutical supply chain and in ensuring patients across the United States have timely and reliable access to prescribed medications, where and when they need them.”

Bob Mauch, President & CEO of Cencora

Cencora’s investments also include opening a second national distribution center in Ohio + an expanded presence in California. The goal is to increase capacity, improve efficiency and enhance the resilience of its national distribution network.

Keep reading to learn more about the company’s investment in Alabama.

Cencora

The Cencora facility is located at 2801 Horace Shepard Dr. in Dothan. It’s one of three Cencora facilities dedicated to specialty medicines.

Specialty pharmaceuticals are used to treat complex, chronic or rare medical conditions. The growth in specialty medicines is mirrored by the increased demand for specialized supply chain logistics.

The Dothan expansion is expected to be completed by fall 2026.

The company hopes it will increase the facility’s refrigerated storage capacity by 500% and its frozen storage capacity by 200%, enhancing Cencora’s ability to handle complex specialty medications and its operational resilience.

“We’re committed to delivering an industry-leading customer experience — and that starts with listening to our customers, anticipating their needs and making strategic investments to ensure we can provide the exceptional service they expect. As demand continues to grow and more specialty pharmaceuticals reach the market, the investments we’re making today will strengthen our ability to support our customers’ current and future needs, enabling them to continue delivering high-quality patient care in their communities.”  

Rich Tremonte, Executive Vice President and President, U.S. Pharmaceuticals and Animal Health at Cencora

Want updates like this delivered straight to your inbox? Sign up for our newsletter today.